UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytomegalovirus in Solid Organ Transplantation

American journal of transplantation, 2013-03, Vol.13 (s4), p.93-106

2013

Volltextzugriff (PDF)

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

American journal of transplantation, 2017-09, Vol.17 (9), p.2468-2473

2017

Volltextzugriff (PDF)

CMV: Prevention, Diagnosis and Therapy

American journal of transplantation, 2013-02, Vol.13 (s3), p.24-40

Kotton, C. N.

2013

Volltextzugriff (PDF)

Cytomegalovirus in Solid Organ Transplant Recipients

American journal of transplantation, 2009-12, Vol.9, p.S78-S86

2009

Volltextzugriff (PDF)

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

American journal of transplantation, 2020-06, Vol.20 (6), p.1703-1711

2020

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

American journal of transplantation, 2019-02, Vol.19 (2), p.573-584

2019

Volltextzugriff (PDF)

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.290-299

2012

Volltextzugriff (PDF)

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

American journal of transplantation, 2015-10, Vol.15 (10), p.2655-2664

2015

Volltextzugriff (PDF)

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

American journal of transplantation, 2020-08, Vol.20 (8), p.2070-2080

2020

Volltextzugriff (PDF)

Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients

American journal of transplantation, 2023-12, Vol.23 (12), p.1961-1971

2023

Volltextzugriff (PDF)

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

American journal of transplantation, 2021-12, Vol.21 (12), p.3958-3970

2021

Volltextzugriff (PDF)

Antiviral toxicities in pediatric solid organ transplant recipients

American journal of transplantation, 2022-12, Vol.22 (12), p.3012-3020

2022

Volltextzugriff (PDF)

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

American journal of transplantation, 2013-07, Vol.13 (7), p.1793-1805

2013

Volltextzugriff (PDF)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Volltextzugriff (PDF)

Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study

American journal of transplantation, 2021-10, Vol.21 (10), p.3449-3455

2021

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.284-292

2011

Volltextzugriff (PDF)

Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy

American journal of transplantation, 2019-09, Vol.19 (9), p.2457-2467

2019

Volltextzugriff (PDF)

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study

BMC infectious diseases, 2022-02, Vol.22 (1), p.155-155, Article 155

2022

Volltextzugriff (PDF)

Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity

Current opinion in infectious diseases, 2021-08, Vol.34 (4), p.307-313

2021

Volltextzugriff (PDF)

CMV antiviral stewardship: navigating obstacles to facilitate target attainment

Current opinion in organ transplantation, 2023-02, Vol.28 (1), p.8-14

2023

Volltextzugriff (PDF)

Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients

American journal of transplantation, 2006-09, Vol.6 (9), p.2134-2143

2006

Volltextzugriff (PDF)

Recent advances in cytomegalovirus infection management in solid organ transplant recipients

Current opinion in organ transplantation, 2024-04, Vol.29 (2), p.131-137

2024

Volltextzugriff (PDF)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

BMC infectious diseases, 2015-12, Vol.15 (581), p.582-582, Article 582

2015

Volltextzugriff (PDF)

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression

Frontiers in immunology, 2018-12, Vol.9, p.2953-2953

2018

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

KollektionIngentaConnect Journals

ThemaTransplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(186)

Publikationsform

Artikel
(204)

Sprache

Englisch
(204)

Erscheinungsjahr

n.n

Thema

Science & Technology
(201)
Life Sciences & Biomedicine
(196)
Humans
(193)
Cytomegalovirus Infections - Prevention & Control
(137)
Cytomegalovirus
(131)
Female
(110)
Male
(110)
Surgery
(105)
Adult
(88)
Middle Aged
(85)
Antiviral Agents - Therapeutic Use
(83)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Risk Factors
(57)
Ganciclovir - Therapeutic Use
(53)
Retrospective Studies
(53)
Immunology
(51)
Adolescent
(47)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(47)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cytomegalovirus in Solid Organ Transplantation

An Interventional Study Using Cell‐Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation

CMV: Prevention, Diagnosis and Therapy

Cytomegalovirus in Solid Organ Transplant Recipients

Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

Monitoring of CMV‐specific cell‐mediated immunity with a commercial ELISA‐based interferon‐γ release assay in kidney transplant recipients treated with antithymocyte globulin

Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients

Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti‐viral prophylaxis at play?

Antiviral toxicities in pediatric solid organ transplant recipients

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study

Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity

CMV antiviral stewardship: navigating obstacles to facilitate target attainment

Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients

Recent advances in cytomegalovirus infection management in solid organ transplant recipients

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression

Aktive Filter

Suchergebnisse filtern